Anchor Investment Management’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.1K | Hold |
58
| – | – | ﹤0.01% | 887 |
|
2025
Q1 | $5.29K | Hold |
58
| – | – | ﹤0.01% | 873 |
|
2024
Q4 | $5K | Hold |
58
| – | – | ﹤0.01% | 879 |
|
2024
Q3 | $5.51K | Hold |
58
| – | – | ﹤0.01% | 865 |
|
2024
Q2 | $5.31K | Hold |
58
| – | – | ﹤0.01% | 836 |
|
2024
Q1 | $5.26K | Hold |
58
| – | – | ﹤0.01% | 859 |
|
2023
Q4 | $4.72K | Hold |
58
| – | – | ﹤0.01% | 821 |
|
2023
Q3 | $4.63K | Hold |
58
| – | – | ﹤0.01% | 837 |
|
2023
Q2 | $4.57K | Hold |
58
| – | – | ﹤0.01% | 838 |
|
2023
Q1 | $4.5K | Hold |
58
| – | – | ﹤0.01% | 845 |
|
2022
Q4 | $4.51K | Hold |
58
| – | – | ﹤0.01% | 809 |
|
2022
Q3 | $3.9K | Hold |
58
| – | – | ﹤0.01% | 832 |
|
2022
Q2 | $4.46K | Hold |
58
| – | – | ﹤0.01% | 825 |
|
2022
Q1 | $4.63K | Hold |
58
| – | – | ﹤0.01% | 853 |
|
2021
Q4 | $4.46K | Hold |
58
| – | – | ﹤0.01% | 881 |
|
2021
Q3 | $4.22K | Hold |
58
| – | – | ﹤0.01% | 800 |
|
2021
Q2 | $4.24K | Hold |
58
| – | – | ﹤0.01% | 822 |
|
2021
Q1 | $4K | Hold |
58
| – | – | ﹤0.01% | 806 |
|
2020
Q4 | $3.86K | Hold |
58
| – | – | ﹤0.01% | 783 |
|
2020
Q3 | $3.61K | Hold |
58
| – | – | ﹤0.01% | 760 |
|
2020
Q2 | $3.61K | Hold |
58
| – | – | ﹤0.01% | 740 |
|
2020
Q1 | $3.16K | Hold |
58
| – | – | ﹤0.01% | 729 |
|
2019
Q4 | $3.72K | Hold |
58
| – | – | ﹤0.01% | 730 |
|
2019
Q3 | $3.31K | Hold |
58
| – | – | ﹤0.01% | 727 |
|
2019
Q2 | $3.4K | Hold |
58
| – | – | ﹤0.01% | 717 |
|
2019
Q1 | $3.52K | Hold |
58
| – | – | ﹤0.01% | 714 |
|
2018
Q4 | $3.18K | Hold |
58
| – | – | ﹤0.01% | 732 |
|
2018
Q3 | $3.73K | Hold |
58
| – | – | ﹤0.01% | 748 |
|
2018
Q2 | $3.42K | Hold |
58
| – | – | ﹤0.01% | 767 |
|
2018
Q1 | $3.3K | Hold |
58
| – | – | ﹤0.01% | 741 |
|
2017
Q4 | $3.44K | Buy |
+58
| New | +$3.44K | ﹤0.01% | 742 |
|